Ciprofloxacin Hydrochloride

CAS 86393-32-0 13 current records 9 historicalSmall Molecule

Who holds supplier records for Ciprofloxacin Hydrochloride? 13 organisations hold a current record for Ciprofloxacin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (2), Germany (1), Spain (1) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ciprofloxacin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ciprofloxacin-hydrochloride

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ciprofloxacin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • AARTI DRUGS LTD
    Active DMF 19611 · latest filing Jul 2006
    IndiaCEP Company GMP cert on record
  • Bayer AG
    Active DMF 8134 · latest filing Jul 1989
    GermanyCEP Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 13862 · latest filing Nov 1998
    IndiaCEP Company GMP cert on record
  • Neuland Laboratories Limited
    Active DMF 13250 · latest filing Sept 1998
    IndiaCEP
  • QUIMICA SINTETICA SA
    Active DMF 8517, 11966 · latest filing Feb 1996
    SpainCEP Company GMP cert on record
  • PHLOW CORP
    Active DMF 37206 · latest filing Dec 2024
    United States
  • Taro Pharmaceutical Industries Ltd.
    Active DMF 17933 · latest filing Dec 2004
    Israel Company GMP cert on record
  • THINQ PHARMA-CRO LTD
    Active DMF 30616 · latest filing Jun 2016
    India
  • TURTLE PHARMA PRIVATE LTD
    Active DMF 33245 · latest filing Oct 2018
    India
  • UNION QUIMICO FARMACEUTICA SA
    Active DMF 17061, 11602 · latest filing Dec 2003
  • Zhejiang Huayi Pharmaceutical Co., Ltd.
    Active DMF 18083 · latest filing Dec 2004
    China
  • Sun Pharmaceutical Industries Limited
    Inactive DMF 13072 · latest filing Jul 1998
    IndiaCEP Company GMP cert on record
  • ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Ciprofloxacin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Ciprofloxacin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 1998-090 - Rev 15
Ciprofloxacin Hydrochloride
Oct 2026—
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2000-405 - Rev 14
Ciprofloxacin Hydrochloride
Sept 2026—
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. ShaoxingCN
CEP 2019-007 - Rev 05
Ciprofloxacin Hydrochloride, Process 105
May 2025Inspected Mar 2025
Germany
BAYER AG LeverkusenDE
CEP 1998-103 - Rev 07
Ciprofloxacin Hydrochloride
Jan 2025—
AARTI DRUGS LIMITED MumbaiIN
CEP 2005-119 - Rev 06
Ciprofloxacin Hydrochloride
Jan 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2003-013 - Rev 08
Ciprofloxacin Hydrochloride
Dec 2024—
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 1999-096 - Rev 09
Ciprofloxacin Hydrochloride
Oct 2024Inspected Apr 2025
Spain

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Ciprofloxacin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 9 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ciprofloxacin Hydrochloride is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antimicrobial agents.

Chemical identity

IUPAC name
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride
Canonical SMILES
C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.O.Cl
InChIKey
ARPUHYJMCVWYCZ-UHFFFAOYSA-N
Synonyms
Cipro API, bay o 9867 monohydrate, bay-o-9867 monohydrate, cetraxal, ciflox, ciloxan, cipro, ciprobay, ciprofloxacin (as hydrochloride), ciprofloxacin hcl, ciprofloxacin hydrochloride hydrate, ciprofloxacin hydrochloride monohydrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Fluoroquinolone Antibacterial; Quinolone Antimicrobial
Mechanism of action
Cytochrome P450 1A2 Inhibitors
Chemical structure
Fluoroquinolones; Quinolones

Therapeutic areas

Infectious DiseasesRespiratory InfectionsUrinary Tract Infections

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ciprofloxacin Hydrochloride?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Ciprofloxacin Hydrochloride: AARTI DRUGS LTD (India), Bayer AG (Germany), Dr. Reddy's Laboratories Ltd. (India), Neuland Laboratories Limited (India), QUIMICA SINTETICA SA (Spain), PHLOW CORP (United States), Taro Pharmaceutical Industries Ltd. (Israel) and THINQ PHARMA-CRO LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ciprofloxacin Hydrochloride Drug Master Files are active?

AARTI DRUGS LTD (DMF 19611), Bayer AG (DMF 8134), Dr. Reddy's Laboratories Ltd. (DMF 13862), Neuland Laboratories Limited (DMF 13250), QUIMICA SINTETICA SA (DMF 8517, 11966), PHLOW CORP (DMF 37206), Taro Pharmaceutical Industries Ltd. (DMF 17933) and THINQ PHARMA-CRO LTD (DMF 30616) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ciprofloxacin Hydrochloride records mean?

9 organisations have only inactive Type II DMFs for Ciprofloxacin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ciprofloxacin Hydrochloride have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Ciprofloxacin Hydrochloride on the EDQM register, including SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), NEULAND LABORATORIES LIMITED Hyderabad (IN), ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing (CN), BAYER AG Leverkusen (DE), AARTI DRUGS LIMITED Mumbai (IN) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ciprofloxacin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ciprofloxacin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.